J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
Developing innovative medicines solutions
- B2B
- B2G
- Has physical offices
- Manufacturing
- Sales-led purchase
About J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
A global pharmaceutical organization dedicated to developing treatments for diseases and collaborating with partners worldwide to improve patient outcomes
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Beerse, Antwerp, Belgium
- Revenue
- $127M – $1BTamtam estimate
- Website
- innovativemedicine.jnj.com
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) in the news
- Focused on developing medicines for some of the world’s most complex and devastating diseases
Janssen Sciences Ireland UC develops innovative medicines for complex diseases, operates major manufacturing sites in Cork, and calls for improved healthcare funding and infrastructure in Ireland to enhance patient access and support value-based care.
- From graduate to chairman: My 30 years in pharma
A Janssen leader reflects on his 30-year career journey, emphasizing purpose, equal opportunity, and leadership diversity in pharma.
- When Europe Treats Healthcare Innovation as a Cost, Patients Pay the Price
Europe's focus on healthcare cost-cutting, driven by budget constraints and aging populations, negatively impacts patients, health systems, and economies by neglecting the long-term value of innovation.
- Harnessing Europe’s Data Potential: How HONEUR Can Help Improve Patient Outcomes
Europe can enhance patient outcomes by better leveraging real-world data through federated networks and policy initiatives to improve healthcare decision-making and access to innovative treatments.
- ICOTYDE™ (icotrokinra) one-year results demonstrate lasting skin clearance and favourable safety profile in once-daily tablet for plaque psoriasis
Johnson & Johnson successfully completed one-year Phase 3 trials for its oral psoriasis pill icotrokinra, showing lasting skin clearance in adults and adolescents.
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) at a glance
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) is a B2B/B2G company in the Pharmaceutical Manufacturing industry, headquartered in Beerse, Antwerp, Belgium.
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) has 251–1,000 employees.
J&J Innovative Medicine Europe, Middle East & Africa (EMEA)'s revenue is $127M – $1B (Tamtam estimate).
Selling to companies like J&J Innovative Medicine Europe, Middle East & Africa (EMEA)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies